Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia
Year: 2019
Type: article
Study design: Observational Study
Source: Obesity Surgery
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: post-bariatric hypoglycemia, FGF19
Open Access status: green
Funders: American Diabetes Association, Sanofi, Harvard Catalyst, Dexcom, Aase og Ejnar Danielsens Fond, Novo Nordisk, MedImmune, Danmarks Frie Forskningsfond, Augustinus Fonden, Novo Nordisk Fonden, National Institutes of Health, School of Medicine, Stanford University, Diabetes Research Center, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences, Janssen Pharmaceuticals, H2020 European Research Council
Awards: Spectrum Stanford Center for clinical and Translational Research and Education, Spectrum Stanford Center for clinical and Translational Research and Education, G2833296188, Reaching the effects of gastric bypass on diabetes and obesity without surgery, G2997693171, G3472036605, G3615943839, G3875032289, G480176965, G4948835337, G5214398582, Comparative Effectiveness of Medical Therapy vs. Bariatric Surgery for Obese T2DM, G6097837718, Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia, G7060033699, Harvard Clinical and Translational Science Center, G8394906821, Training Grant in Diabetes and Metabolism, Diabetes Research Center, Durability and Mechanisms of Bariatric Surgery vs Medical Therapy in Obese T2D
OpenAlex ID: W2938459224
